Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (4)
  • 2024 (4)
  • 2023 (12)
  • 2022 (13)
  • 2021 (13)
  • 2020 (3)
  • 2019 (3)
  • 2018 (1)

Subject

  • Drug Trafficking (1728)
  • Synthetic drugs (660)
  • Fake Pills (530)
  • Guns/Weapons (466)
  • OCDETF/Task Force (397)
  • Seizures (Drugs/Property) (241)
  • Arrests/Convictions - Major (236)
  • Overdose (218)
  • Guilty Plea (165)
  • Major Law Enforcement Operation (120)
  • Task Forces/Task Force Officers (108)
  • Fentanyl Awareness (79)
  • One Pill Can Kill (67)
  • Gangs (59)
  • Outreach/Drug Prevention (53)
  • HIDTA (52)
  • Money Laundering (52)
  • Press Conferences (39)
  • Diversion Division (28)
  • Pharmaceuticals/Pharmacists/Physicians (26)
  • Narcoterrorism (22)
  • Prevention/Education - DEA websites GSAD, JTT etc (19)
  • Extraditions (12)
  • Asset Forfeiture (10)
  • Dark Web- Internet Trafficking (10)
  • Public and Media Affairs - also see Congressional Affairs (10)
  • International/Foreign Operations (4)
  • Intelligence Division - Intelligence Products (2)
  • Terrorism (2)
  • Congressional Affairs (1)
  • Critical Incident (1)
  • El Paso Intelligence Center (1)
  • Fentanyl Free America (1)
  • Intergovernmental Affairs (1)
  • Other (1)
  • Take Back Day (1)
  • Prescription Drugs (53)

Drug Name

  • Oxycodone (75)
  • Opioids (57)
  • Synthetic Opioids (21)
  • Hydromorphone (18)
  • Benzodiazepines (13)
  • Methamphetamine (13)
  • Morphine (10)
  • Amphetamines (9)
  • Cocaine (8)
  • Heroin (6)
  • Methadone (5)
  • Marijuana (Cannabis) (3)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)
  • Fentanyl (53)

Field Division

  • Washington, DC (13)
  • St. Louis (11)
  • New York (6)
  • Dallas (5)
  • New England (5)
  • Seattle (3)
  • Chicago (2)
  • Headquarters (2)
  • Houston (2)
  • Atlanta (1)
  • Los Angeles (1)
  • Phoenix (1)
  • San Francisco (1)
Clear All Results
PRESS RELEASE

Former Angels Communications Director Eric Kay Convicted in Tyler Skaggs Overdose Case

February 17, 2022
Dallas - An ex-employee of the Los Angeles Angles was convicted today in connection with the 2019 overdose death of Angles pitcher Tyler Skaggs, announced Eduardo A. Chávez, Special Agent in Charge of DEA Dallas/Fort Worth After less than an hour and a half of deliberation, a federal jury found...
February 17, 2022
PRESS RELEASE

Distributor Convicted of Conspiring to Distribute Controlled Substances and Defrauding the DEA

February 02, 2022
NEW YORK – Damian Williams, the United States Attorney for the Southern District of New York announced that Laurence F. Doud III, the former Chief Executive Officer of Rochester Drug Co-Operative, Inc. (RDC), was convicted today in Manhattan federal court of conspiring to distribute unlawfully, oxycodone and fentanyl, and conspiring...
February 02, 2022
PRESS RELEASE

Thirteen Arrested for Fentanyl Distribution

January 05, 2022
AUSTIN – Today 13 individuals were arrested on criminal charges for their alleged involvement in fentanyl distribution announced Drug Enforcement Administration (DEA) Special Agent in Charge Daniel C. Comeaux and United States Attorney Ashley C. Hoff. According to court documents, Marcos Garcia, 18, of Somerton, AZ; Oliver Garcia, 20, of...
January 05, 2022
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

November 30, 2021
Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...
November 30, 2021
PRESS RELEASE

Man Indicted for Taking Controlled Substances from Kansas Hospital

November 01, 2021
KANSAS CITY, Kan. – A federal grand jury in Kansas returned an indictment charging an Overland Park, Kansas, man on two counts of tampering with a consumer product, one count of possession of fentanyl by deception and subterfuge, and one count of possession of hydromorphone by deception and subterfuge. According...
November 01, 2021
PRESS RELEASE

Missouri Woman Indicted for Tampering with Hospitals’ Fentanyl

October 04, 2021
KANSAS CITY, Kan. – A federal grand jury in Kansas City, Kansas, returned an indictment charging a nurse from Kansas City, Missouri, with two counts of tampering with a consumer product and two counts of possession of fentanyl by deception and subterfuge. According to court documents, between January 2020 and...
October 04, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

September 27, 2021
WASHINGTON, DC – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
September 27, 2021
PRESS RELEASE

DEA Washington Chief Issues Public Safety Alert: Dangerous Increase in Fake Rx Pills Containing Fentanyl

September 27, 2021
Washington, D.C. – Today, Jarod Forget, Special Agent in Charge of the DEA Washington Division issued a Public Safety Alert warning Maryland, Virginia, and Washington, D.C. residents of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl in our area. This DEA Public Safety Alert...
September 27, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

September 27, 2021
PHOENIX - Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide surge...
September 27, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

September 27, 2021
LOS ANGELES – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
September 27, 2021
Showing 31 - 40 of 53 results

Pagination

  • First page «
  • Previous page ‹
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Page 6
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster